Wednesday, 17 July 2024

The World's First $1 Trillion Drug

Dear Reader,
 
It’s being called “a miracle.” 

And the “holy grail of medicine.”

That’s “widely expected to be one of the top-selling medicines in history.”

They’re talking about new drugs called “GLP-1 agonists.”

And everybody’s raving about them because they make weight loss easy. 

No diet and no exercise required.

It’s a dream come true for dieters.

Which is why some Wall Street analysts are predicting these drugs will generate $200 billion annually by 2030. 

That’s more revenue than the current top-10 selling medicines generate… combined.

But former hedge fund manager Ian King says Wall Street is WRONG.

Because of one line he found in this official FDA document, he says Wall Street is vastly UNDERESTIMATING the potential. 

Instead…

Ian predicts this could become the world’s first trillion-dollar drug. And he’s recommending 3 little-known stocks to play this fast-moving trend. 
 
 
 
 
Regards,
 
 
Sarah Williams
Associate Editorial Manager, Banyan Hill Publishing
 
P.S. This is a time-sensitive opportunity.

Because of what Ian found in this FDA document, he believes the FDA could make a major announcement about GLP-1 drugs within the next 6 months.

If that happens, he says the share prices of the 3 little-known stocks he’s recommending could skyrocket. 
 
 
This ad is sent on behalf of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. 
If you would like to unsubscribe from receiving offers for Strategic Fortunes, please click here .

 

 
Stockguru LLC (dba InvestingChatter)
711 SW 24th Ave Boynton, Beach, FL 33435 

This email is being sent from InvestingChatter.
If you no longer wish to receive InvestingChatter emails, please  click to unsubscribe.
DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.
xpdt_17211728

The World’s First $1 Trillion Drug

Dear Reader,
 
It’s being called “a miracle.” 

And the “holy grail of medicine.”

That’s “widely expected to be one of the top-selling medicines in history.”

They’re talking about new drugs called “GLP-1 agonists.”

And everybody’s raving about them because they make weight loss easy. 

No diet and no exercise required.

It’s a dream come true for dieters.

Which is why some Wall Street analysts are predicting these drugs will generate $200 billion annually by 2030. 

That’s more revenue than the current top-10 selling medicines generate… combined.

But former hedge fund manager Ian King says Wall Street is WRONG.

Because of one line he found in this official FDA document, he says Wall Street is vastly UNDERESTIMATING the potential. 

Instead…

Ian predicts this could become the world’s first trillion-dollar drug. And he’s recommending 3 little-known stocks to play this fast-moving trend. 
 
 
 
 
Regards,
 
 
Sarah Williams
Associate Editorial Manager, Banyan Hill Publishing
 
P.S. This is a time-sensitive opportunity.

Because of what Ian found in this FDA document, he believes the FDA could make a major announcement about GLP-1 drugs within the next 6 months.

If that happens, he says the share prices of the 3 little-known stocks he’s recommending could skyrocket. 
 
 
This ad is sent on behalf of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. 
If you would like to unsubscribe from receiving offers for Strategic Fortunes, please click here.

 

 

Market Rotation — What’s Actually Happening

tech went out of style fast
 
   
     
   
 
JULY 17, 2024
   
PROSPERITY PUB MARKET TALK
Market Rotation — What’s Actually Happening
 
 
For a few weeks now, our own Nate Tucci has pointed out the possibility of a sector rotation happening in the markets.

And it looks like that rotation may have gone into full effect over the past few trading sessions as the once-unstoppable Nasdaq seems to have stalled out to the benefit of other sectors: health, financial, discretionary — even the floundering small-cap Russell 2000 Index (IWM) has caught fire.

It seems to be down to a couple of things: With tech having led much of the year's rally so far, multiples were already getting sky high.

Meanwhile, the Fed's softening stance on possible rate cuts come at a great time for small businesses, increasing the possibilities for the type of growth and lending environment that stand to benefit small caps.

And even, as Nate pointed out Monday, the unfortunate attempt on former President Trump's life seems to have reanimated the Republican's campaign —  with even Wall Street betting a second Trump presidency could be good for business outside of just the largest large caps.

The interest rate part of the equation is also interesting. Especially if you read Nate's piece on the onerous burden of government regulation on small business.

But this kind of onerous burden doesn't stop at regulation. Interest rates also disproportionately affect small businesses, which have less resources and need to rely more on loans than their larger counterparts.

Think about it, large businesses — household names like Microsoft, Amazon, Apple and others — have more resources, not to mention larger piles of cash with which to insulate themselves.

In the kind of inflationary, high-interest-rate environment we've been in, it's no wonder small caps have been floundering all year.

Meanwhile, even though nothing has actually changed with rates yet — as Nate has often said — sometimes dangling the carrot is better than the actual carrot itself. It seems as though just the thought that the Fed might lower rates is enough to spark optimism.

Nate summed up the market shift and resulting chaos nicely in his FREE Telegram channel… Be sure to click and join for free trades and guidance as the new market reality continues evolving:

 
 

— The Prosperity Pub Team
 
Tiny Stock Moves = Massive Opportunities

Discover Nate Tucci’s revolutionary “Jump Trades”… Which targets tiny 1% stock moves to leverage huge options gains.

With real-time trades averaging 237% winners and a 56.7% win rate, it’s perfect for small accounts!

Don’t miss this groundbreaking opportunity!


Click here to get all the details now!
GEOF SMITH'S TAKE
A Case Study In Finding Potential Winners (BYRN)
 

I've been getting some questions about my recommendation on BYRN (Byrna Technologies) back on January’s episode of Publisher’s Roundtable.

So, I thought it would be a good time to revisit this stock and give you some insights into my process and what I see in store for it.

You might remember that I pointed out BYRN when it was trading around $7. Since then, it ran up as high as $15 — more than a 200% return in a short period of time.

Naturally, after such a big run, it corrected back, but I still see a lot of potential upside.

I first heard about Byrna when my wife brought it to my attention.

She was looking into their products, specifically the Byrna gun, which is essentially a high-tech paintball gun.

She liked the concept of a non-lethal self-defense option, and that got me curious.

I started digging into the company and found that it was a standalone entity with a solid product that could appeal to a broad market, particularly women who might be hesitant to carry a traditional firearm.

As I said, while we got in early and it quickly ran up to $15, after such a quick rise, it’s only natural to expect a pullback.

And it sure has pulled back, where it currently sits just above $10 per share.

But that’s not the end of the story for Byrna. As long as it holds above the $9 area, I think it's still a buy.

In the longer term, I can see this stock reaching $25 to $30.

What's also exciting is that Byrna recently signed a deal with the Argentinian police to supply them with Byrna guns.

This kind of expansion into law enforcement could be a game-changer. I believe they'll continue to penetrate more markets and municipalities, driving further growth.

For those who are already in, I suggest holding onto it.

For new investors, consider selling puts to acquire it at a lower price and take advantage of the potential upside.

This approach has worked well for me in the past, and I believe BYRN has a bright future ahead.

Remember, investing in stocks often means looking beyond the numbers and considering the practical appeal of a product. If it's something you or your loved ones find valuable, chances are others will too.

I’ll talk more about that in a future update.


— Geof Smith
   
 

Exclusive Early Access: Invest in the Next Media Powerhouse!

Exclusive Early Access: Invest in the Next Media Powerhouse!

Unlock the future of media with a rare Reg A+ opportunity! As an early-stage investor, you'll gain access to a groundbreaking company poised to revolutionize the $786.2 billion digital marketing industry. Don't miss your chance to be part of this media evolution and secure your place in the next big success story. Act now and ride the wave of innovation and growth! [ad]

Join the AI media revolution-invest today and see the future unfold!
The #1 free indicator I've used for 30+ years

You would've traded Nvidia, Tesla, Netflix... all the big names and had a shot at making money following me the last few years. All you needed was one, free indicator. It's one I've never heard anyone else use, but I've traded with it full-time for the last 30 years. 

This indicator alerts me when I should be buying and when to sell. [ad]

The indicator is free... and the 23-page book I wrote for you is also free.
7 Once in a Decade Buying Opportunities

Eric Fry has been right about a lot of stock picks. 41 recommendations that increased over 1,000%. Another 20 that went up more than 500%. He's good. So if he releases a surprise list of 7 companies he expects to win big in 2024, you can't afford to miss it. 

The research is available in a new report that is available...FREE. [ad]

You can download it today.
Up 167% In 2024! Is This Growth Stock Showing Any Signs Of Slowing?

The tech sector's been on fire in 2024. However, few companies can match the blistering pace set by semiconductor giant Nvidia (NASDAQ: NVDA). With its stock price surging an eye-popping 167% since January, many investors are wondering if this growth stock has more fuel left in the tank, or if it's finally due for a cool down.









DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

Stockguru LLC (dba UpTrendAlerts), 711 SW 24th Ave, Boynton Beach, FL 33435, United States
You may unsubscribe or change your contact details at any time.

Historic heat waves have folks begging for winter

How to keep your trading HOT this summer!
 
   
     
You can't deny it's heating up this summer… 
 
 
… So why should your trading do the opposite? 

Jack Carter is ALL about tapping into the hottest stocks of summer this year and he wants to teach you:

 
About his top summer stocks: get Jack’s curated watchlist of the best stocks for summer, helping you stay ahead of the market 
Identify trending stocks: learn the tools and methods Jack uses to spot upward-trending stocks, increasing your chances of finding great opportunities 
Avoid costly mistakes and know when to sell: find out which stocks to avoid and learn Jack’s method for determining the best time to sell, so you have a better shot at protecting your profits and minimizing losses

Uncover it ALL for FREE in Jack HOTTEST Stocks of Summer training HERE

Hope you do, 

Your friends at ProsperityPub 
   
 

Quant King’s Next Big AI Play

The unexpected places you need to look…   December 21, 2024 Quant King’s Next Big AI Play By Michael Salvatore, ...